| 1 |
27896589 | Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer. | 2017 Feb |
2 |
| 2 |
23272153 | Parametric model of combination therapy for Non-Hodgkin Lymphoma. | 2012 |
2 |
| 3 |
17089128 | Blockade of STAT3 by antisense oligonucleotide in TNBS-induced murine colitis. | 2007 Jun |
1 |
| 4 |
17172711 | Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles. | 2007 |
1 |
| 5 |
17656095 | p53-mediated activation of miRNA34 candidate tumor-suppressor genes. | 2007 Aug 7 |
1 |
| 6 |
15561778 | Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma. | 2004 Nov |
1 |
| 7 |
11855753 | Pharmacokinetics of Bcl-2 antisense oligonucleotide (G3139) combined with doxorubicin in SCID mice bearing human breast cancer solid tumor xenografts. | 2002 Jan |
1 |
| 8 |
11948143 | Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma. | 2002 Apr |
1 |
| 9 |
12197229 | Bcl-2 and androgen receptor gene expression in androgen-independent subclone derived from mouse androgen-dependent cells. | 2002 |
1 |
| 10 |
12568310 | Antitumor effect of G3139 Bcl-2 antisense oligonucleotide is independent of its immune stimulation by CpG motifs in SCID mice. | 2002 Dec |
1 |
| 11 |
11259472 | Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins. | 2001 Mar 21 |
1 |
| 12 |
10733680 | Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice. | 2000 Apr |
1 |
| 13 |
10767594 | Physicochemical and biological characterisation of an antisense oligonucleotide targeted against the bcl-2 mRNA complexed with cationic-hydrophilic copolymers. | 2000 May |
2 |
| 14 |
10873104 | Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide. | 2000 Jun |
1 |
| 15 |
11095261 | Chemosensitisation of malignant melanoma by BCL2 antisense therapy. | 2000 Nov 18 |
2 |
| 16 |
9488052 | Overexpression of bcl-2 alters usage of mutational hot spots in germinal center B cells. | 1997 Oct |
1 |
| 17 |
8599976 | BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. | 1996 Feb |
1 |
| 18 |
8605968 | Stromal cells regulate bcl-2 and bax expression in pro-B cells. | 1996 Apr |
1 |
| 19 |
7669664 | BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation. | 1995 Aug |
1 |
| 20 |
8084613 | Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. | 1994 Oct |
2 |